Millington, NJ, United States of America

Andrew L Zeitlin

This inventor holds 26 USPTO granted patents and 15 published patent applications, plus 4 CIPO patents and 3 EPO patents, primarily in Cancer Treatment. Top assignees: Celgene Corporation, Anthrogenesis Corporation, Celegene Corporation. Active years: 1990-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew L Zeitlin. Retrieved from https://idiyas.com/inventor/andrew-l-zeitlin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 (Patent Applications = 15)

% Patents Active = 76.9

CIPO Patents = 4

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 3.0

ph-index = 16

Forward Citations = 1,286(Granted Patents)

Location History:

Green Brook, NJ (US) (1990 - 1992)
Somerville, NJ (US) (1994)
Millington, NJ (US) (1994 - 2008)
Somerset, NJ (US) (2015)
Basking Ridge, NJ (US) (2005 - 2016)

Company Filing History:

Anthrogenesis Corporation

University of Arkansas

patents

5. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1990-2016

Loading Chart...

Areas of Expertise:

Natural Killer Cells

Tumor Suppression

Erythrocytes

Placental Stem Cells

Thalidomide

Irinotecan

Colorectal Cancer

Cognitive Disorders

D-Threo Methylphenidate

Chiral Amines

Stereoisomeric Enrichment

Drug Formulations

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9464274 - Methods of generating natural killer cells (2016-10-11),

2. 9216200 - Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells (2015-12-22),

3. 9200253 - Method of producing erythrocytes (2015-12-01),

4. 8926964 - Methods of generating natural killer cells (2015-01-06),

5. 8455250 - Co-culture of placental stem cells and stem cells from a second source (2013-06-04),

6. 8263065 - Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells (2012-09-11),

7. 7700090 - Co-culture of placental stem cells and stem cells from a second source (2010-04-20),

8. 7479499 - Methods of using thalidomide in combination with irinotecan (2009-01-20),

9. 7435726 - Compositions and methods for the treatment of cancer (2008-10-14),

10. 7431944 - Delivery of multiple doses of medications (2008-10-07),

11. 7115631 - Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate (2006-10-03),

12. 6914067 - Compositions and methods for the treatment of colorectal cancer (2005-07-05),

13. 6635284 - Delivery of multiple doses of medications (2003-10-21),

14. 6602887 - Chronic, bolus administration of D-threo methylphenidate (2003-08-05),

15. 6528530 - Phenidate drug formulations having diminished abuse potential (2003-03-04),

Title: The Inventor Andrew L Zeitlin: Pioneering Innovations in Millington, NJ

Introduction: Andrew L Zeitlin is a distinguished inventor based in Millington, NJ, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Andrew L Zeitlin holds several patents in the areas of technology, healthcare, and consumer products, showcasing his versatility and ingenuity in inventing solutions for modern challenges.

Career Highlights: With a career spanning over two decades, Andrew L Zeitlin has consistently pushed the boundaries of innovation, with his inventions garnering recognition for their practicality and impact on society.

Collaborations: Throughout his career, Andrew L Zeitlin has collaborated with leading research institutions, universities, and companies to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Andrew L Zeitlin's passion for innovation and his dedication to creating solutions that improve lives make him a standout figure in the world of inventors, with his work continuing to inspire future generations of innovators.

Profile summary based on public USPTO records.